These effects, together with a preceding report displaying that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 support the strategy of focusing on ACKR3 as a novel solution to modulate the opioid program, which could open up new therapeutic avenues for opioid-similar Issues. A whole new research https://tuckerq837wvh3.blogrenanda.com/profile